학술논문
A novel biomarker GATM suppresses proliferation and malignancy of cholangiocarcinoma cells by modulating the JNK/c-Jun signalling pathways
Document Type
Article
Author
Source
In Heliyon 15 September 2024 10(17)
Subject
Language
ISSN
2405-8440
Abstract
Conclusion GATM acts as a tumour suppressor in CCA by regulating the phosphorylation of the JNK/c-Jun pathway. IDH1 interacted with GATM to regulate CCA progression.